FemTherapeutics
PrivateLast Round
Seed
May 15, 2023
Total Funding Raised
$1.97M
Company Overview
FemTherapeutics is a medical device company specializing in customizable gynecological prosthetics that leverage artificial intelligence and 3D printing to provide personalized therapeutic solutions for women's pelvic health conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Vertical SaaS, 3D Printing, Precision Medicine
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FemTherapeutics Comps
Public and private peers based on sector, stage, and business model.
FemTherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 15, 2023 | ||||
| Angel | Nov 3, 2022 | ||||
| Grant | Sep 1, 2022 |
Key People
Founding team and executive leadership
FemTherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SheBoot | Seed, Angel |
| Capital Angel Network | Angel |
| National Research Council Canada | Grant |
| 2048 Ventures | Seed |
| The M51 Founder Lab | Seed |
FemTherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FemTherapeutics's valuation, stock price, and market status.
